Wednesday, March 10, 2010
Research Driven
Research Philosophy
One of Soy Labs’ core corporate values is transforming innovative science into high quality nutritional products. We emphasize strong basic research with an acute focus on the major health and wellness concerns facing society today such as heart disease, obesity, diabetes, osteoporosis, menopause, cancer and successful aging.
 
Our Research and Development roadmap includes research projects with foresight into the future health needs of today’s consumer as well as expanding the research portfolio of our current products.
 
Continuous clinical trials are the key to the exploration and discovery of new ingredients and formulations that may make a significant difference in the future of preventable and chronic public health challenges. We are currently conducting several human clinical trials on natural soy bioactive components and cardiovascular health. The scientific advisory board of the Research Department here at Soy Labs collaborates with both national and internationally renowned scientists at leading universities and medical centers. Our continuous work covers an array of innovative scientific activities and discourse regarding the latest in plant science & soybean biotechnology.
 
Our commitment to science and innovation is backed by an ongoing investment in research and intellectual property protection. Soy Labs is dedicated to research—it is the foundation of our business and our ingredients. We strive to build a “product innovation pipeline” between universities and the nutrition business community to continually offer products that are in line with market trends and meet consumers’ evolving health needs.
 
Research Partners

Soy Labs has built strong research collaborations with universities across the country.

Our current research partners include:

  • University of Missouri-Columbia
  • Center for Excellence in Nutritional Genomics, University of California, Davis
  • University of California, Berkeley
  • University of Illinois, Urbana-Champaign
     

 

Researchers
Dr. Alfredo Galvez

Lead researcher on the Lunasin peptide is Dr. Alfredo Galvez. Dr. Galvez discovered the Lunasin peptide in 1996 while aiming to improve the nutritional profile of soy protein at the University of California, Berkeley. Dr. Galvez realized that this impressive soy peptide, which is found in small quantities in soybean seeds and soy-based foods, blocks cell division by binding to specific chromosomal proteins called “hypoacetylated histones.”  Because there is consistent epidemiological data regarding soy and cancer prevention, Lunasin was first investigated as a factor that might prevent cancer cells from dividing and multiplying. The mechanism of action for Lunasin and cancer prevention was included in prestigious journals, such as Nature Biotechnology and the Journal of Cancer Research. As Dr. Galvez continued to study Lunasin, it became evident that the soy peptide had another powerful mechanism of action– lowering cholesterol. To learn more, visit www.lunasin.com.



Dr. Galvez discovered the Lunasin peptide in 1996 while aiming to improve the nutritional profile of soy protein at the University of California, Berkeley. Click on photo to learn more.

Collaboration

If you are affiliated with a research institution and are interested in collaborating with Soy Labs on a research study, please email info@lunasin.com.


Lunasin

One of Soy Labs’ goals is to make the latest research information available on the Lunasin peptide.   Scientific publications, poster presentations, and news articles are accessible at www.lunasin.com.


Copyright 2009 by Soy Labs LLC